Chemotherapy of primary brain tumors.
This article covers chemotherapy of malignant astrocytomas, ependymoma, and medulloblastoma. The future direction of anticancer drugs is discussed.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001254:Astrocytoma / Q000188:drug therapy* / Q000473:pathology; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000473:pathology; D001933:Brain Stem; D002648:Child; D000518:Eflornithine; D004806:Ependymoma / Q000188:drug therapy* / Q000473:pathology; D005472:Fluorouracil / Q000008:administration & dosage; D005909:Glioblastoma / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D006918:Hydroxyurea / Q000008:administration & dosage; D008130:Lomustine / Q000008:administration & dosage; D008527:Medulloblastoma / Q000188:drug therapy* / Q000473:pathology; D008727:Methotrexate / Q000008:administration & dosage; D008935:Mitoguazone / Q000008:administration & dosage; D008936:Mitolactol / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local; D009952:Ornithine / Q000008:administration & dosage / Q000031:analogs & derivatives; D011241:Prednisone / Q000008:administration & dosage; D012306:Risk; D013866:Thioguanine / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D008130:Lomustine; D009952:Ornithine; D013866:Thioguanine; D008936:Mitolactol; D008935:Mitoguazone; D005472:Fluorouracil; D011241:Prednisone; D006918:Hydroxyurea; D008727:Methotrexate; D000518:Eflornithine